SKWD:NASDAQSkyward Specialty Insurance Group, Inc. Analysis
Data as of 2026-06-14 - not real-time
$50.05
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Skyward Specialty Insurance delivered a **strong first quarter of 2026**, posting a 44.8% year‑over‑year revenue increase to $475.9 million and net income of roughly $50 million, which lifted trailing EPS to $4.15 and raised forward EPS guidance to $5.51. Margins remain healthy with a gross margin of 30.7%, operating margin of 14.7% and a profit margin of 11.4%, underscoring the company’s ability to convert premium growth into earnings. The stock trades at a **PE of 12.1**, well below the industry average of 16.8, and at a price‑to‑book of 1.82, suggesting a valuation discount relative to peers. Technical indicators are supportive: the MACD is bullish, the RSI sits at 65 indicating continued momentum, volume is increasing, and the price of $50.05 sits just below the near‑term resistance of $51.66 with solid support at $42.5. Despite a **30‑day volatility of 38.9%**, the beta of 0.38 points to limited systematic risk, and the company’s low debt‑to‑equity (≈40%) and solid ROE of 17% add balance sheet resilience. The DCF model implies a fair value of $271.5, translating to a **21% upside** from current levels, reinforcing the case for upside potential. Overall, the blend of robust earnings growth, attractive valuation multiples, and bullish technicals makes SKWD a compelling buy candidate in the near term.
The primary risks stem from the high short‑term volatility typical of specialty insurers and regulatory headwinds inherent to the property‑and‑casualty sector. However, the company’s U.S.‑centric operations limit geographic and currency exposure, and the improving liquidity profile (increasing volume and a $2 billion market cap) mitigates liquidity concerns. Investors should consider adding SKWD on the back of its earnings momentum while monitoring the price action around the $51.66 resistance level.
The primary risks stem from the high short‑term volatility typical of specialty insurers and regulatory headwinds inherent to the property‑and‑casualty sector. However, the company’s U.S.‑centric operations limit geographic and currency exposure, and the improving liquidity profile (increasing volume and a $2 billion market cap) mitigates liquidity concerns. Investors should consider adding SKWD on the back of its earnings momentum while monitoring the price action around the $51.66 resistance level.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD and rising volume
- Strong Q1 earnings and revenue growth
- Price near support with upside to resistance
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued multiples versus industry peers
- Sustained premium and earnings growth
- Low beta and solid balance sheet
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Long‑term upside indicated by DCF fair value
- Consistent profitability and ROE
- Limited geographic and currency exposure
Key Metrics & Analysis
Financial Health
Revenue Growth44.80%
Profit Margin11.36%
P/E Ratio12.1
ROE17.12%
ROA3.01%
Debt/Equity39.68
P/B Ratio1.8
Op. Cash Flow$427.9M
Free Cash Flow$-261792496
Industry P/E16.8
Technical Analysis
TrendNeutral
RSI65.1
Support$42.50
Resistance$51.66
MA 20$46.46
MA 50$45.83
MA 200$46.66
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Fair Value$271.54
Target Price$60.64
Upside/Downside21.15%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.38
Volatility38.98%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
601233
Tongkun Group Co., Ltd. Class A
STOCKPSCU
Invesco S&P SmallCap Utilities & Communication Services ETF
ETFNMZ
Nuveen Municipal High Income Opportunity Fund
CLOSED_END_FUND603290
StarPower Semiconductor Ltd. Class A
STOCKSDTY
YieldMax S&P 500 0DTE Covered Call Strategy ETF
ETF000100
Yuhan Corporation
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.